You are here: Industry Insights > COVID-19

News List

Edesa Biotech gets FDA approval for EB05 trial to treat Covid-19 pharmaceutical-technology
October 22, 2020
Biopharma firm Edesa Biotech has received clearance from the US Food and Drug Administration (FDA) to initiate the Phase II part of Phase II / III clinical trial of its investigational drug EB05 to treat hospitalised patients with Covid-19.
Eiger Announces Positive Results of COVID-19 Trial americanpharmaceuticalreview
October 22, 2020
Eiger BioPharmaceuticals announced results of the ILIAD Study (Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19), an investigator sponsored randomized trial of Peginterferon Lambda (Lambda) in outpatients with ...
Experts partner with UK government for COVID-19 human challenge trials pharmatimes
October 22, 2020
The UK government has joined forces with experts from the NHS, academia and the private sector to explore and establish human challenge trials to aid the development of a COVID-19 vaccine.
Inhaled antibody treatment for COVID-19 shows success in pre-clinical trials europeanpharmaceuticalreview
October 22, 2020
Researchers have developed a monoclonal antibody called AR-711 that is highly neutralising against COVID-19 in an inhaled formulation.
Repurposed drugs not effective treatment for hospitalised COVID-19 patients, WHO says europeanpharmaceuticalreview
October 22, 2020
WHO has said that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon had little or no effect when treating hospitalised patients with COVID-19.
COVID-19 pandemic to heighten sales of pharmaceutical spray drying europeanpharmaceuticalreview
October 22, 2020
A new report has predicted that the COVID-19 pandemic will drive demand for pharmaceutical spray drying, boosting the market.
The Doc Announces New Rapid Detection SARS-CoV-2 Antibody Test Kit, Plans to Alleviate COVID-19 Testing Delays prnewswire
October 22, 2020
The Doc, LLC. announced the development of a new rapid detection serological antibody test kit for SARS-CoV-2, the virus that causes COVID-19. With results in minutes using only a drop of blood, the Company's IgM/IgG antibody test has been submitted for..
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test prnewswire
October 22, 2020
BioReference Laboratories, Inc., an OPKO Health company, is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the diagnosis of ...
Israeli Ministry of Health Authorizes Trial Initiation Evaluating Allocetra for COVID-19 americanpharmaceuticalreview
October 21, 2020
Enlivex Therapeutics reported that the Israeli Ministry of Health authorized the initiation of a proposed investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
NIAID trial to identify potential COVID-19 treatments for further development europeanpharmaceuticalreview
October 21, 2020
The adaptive ACTIV-5/BET study will test two monoclonal antibody therapies in hospitalised COVID-19 patients to establish if they warrant larger clinical trials.